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Objective: The study aimed to evaluate the hematological parameters of patients with dengue fever in order to 
increase the sensitivity of screening for early diagnosis and as an aid to the early institution of appropriate 
treatment.  
Materials and Methods: This study was conducted in Peadiatrics Department Benazir Bhutto Hospital, 
Rawalpindi for a period of 6 months from July 2019 to December 2019.  
Results: During the study period of 6 months, 438 dengue serology-positive children were admitted, amongst 
which 254 were male (58%), and 184 were female (42%). The children's age ranged from 1 month to 12 years, with 
a mean age of 8.03 years (SD + 3.13 years). Out of 438 children, 254 (58%) were uncomplicated dengue fever (DF), 
119 children (27%) developed dengue hemorrhagic fever (DHF). 65 children (15%) went into dengue shock 
syndrome (DSS). The predominant findings in the complete blood picture (CBC) were Thrombocytopenia (80.1%) 
and leucopenia (65.1%). Normal leucocyte count was seen in 59 cases (13.68%). Thrombocytopenia (platelets less 
than 100,000) was seen in 351 patients (80.1%) out of which 30 cases (6.9%) had a platelet count less than 50,000. 
Leukopenia was found in 285 (65.1%) patients. Most of the patients were positive for NS1 (70.3%). IgM was 
positive in 62.1% and IgG was positive in 14.8%. Enteric Fever as co-infection was found in 30(6.8%) children. 
Conclusion:  Careful assessment and interpretation of hematological changes in dengue patients allow early 
diagnosis and institution of appropriate treatment. 
Keywords:  Dengue, platelets, children. 
 




Dengue is a public health concern as it is a global life-
threatening infection. In more than 100 countries it 
affects about 2.5 billion people.1  
Dengue is transmitted by mosquitos and leads to 
arthropod-born viral diseases.2 Dengue virus is a 
member of the Flaviviridae family and has four 
different antigenic types (dengue 1, 2, 3 & 4). The 
principal vector is Aedes agypti which bites during the 
daytime.3 
The main presenting features are fever, headache, 
myalgia, arthralgia, and minor haemorrhagic 
manifestations.4 A wide range of manifestations can 
occur in infection with any of the dengue virus 
infections and vary from mild fever to haemorrhage 
and shock which is life-threatening.5  
Correct and early diagnosis can help improve patient 
management and optimized the use of resources such 
as hospital staff, beds, and equipment.6  
The laboratory test for dengue is of two types, Non-
specific tests like complete blood count and definitive 
tests like dengue serology and NS1 antigen test.7 The 
epidemiological aspects of the disease, the kit, and the 
method used may result in variations in these tests 
results.8  
During the disease process, a series of haematological 
and biochemical changes occur which depend upon 
the clinical disease.9 
The clinical features of dengue infection may resemble 
other infections. The serological tests are expensive 
and are not available in many hospitals.10 Awareness 
of clinical features, as well as laboratory findings like 
haematological and biochemical parameters, are the 
most important guides to therapy and prognosis of 
dengue fever. The haematological and biochemical 
findings reported are thrombocytopenia, anemia, 
leukopenia, elevated levels of AST & ALT.11 Other 
findings are activated lymphocytes on a peripheral 
blood smear.12 Lymphocytosis and neutrophilia and 
raised bilirubin can also occur.13 Changes in 
haematocrit, albumin, and cholesterol can also occur.9 
Other changes are hemoconcentration12, a raised blood 
urea and serum creatinine14, hypokalemia, DIC15 
hypocalcemia.16 The study aimed to evaluate the 
hematological parameters of patients with dengue 
fever to increase the sensitivity of screening for early 
diagnosis and as an aid to the early institution of 




Materials and Methods 
 
This prospective descriptive study was conducted at 
the Department of Pediatrics, Benazir Bhutto Hospital, 
Rawalpindi for a period of 6 months from July to 
December 2019. One month to 12 years old children 
presenting with clinical signs and symptoms of 
dengue fever were admitted to the paediatric dengue 
ward and were included in the study. Patients with 
age more than 12 years or suffering from previously 
known blood disorders were excluded. All children 
attending the hospital with symptoms and signs 
suggestive of dengue fever were tested for NS1 
antigen and IgM/IgG dengue antibody serology 
(depending on the day of fever) by enzyme-linked 
immunosorbent assay (ELISA) technique. Every 
admitted case with confirmed dengue fever was 
enrolled in a structured protocol that included relevant 
hematological investigations. The diagnosis of dengue 
fever was based on the WHO criteria. All this data was 
recorded and entered in the predesigned, pre-tested, 
and semi-structured questionnaire. The relevant data 
was recorded, entered, and analyzed by SPSS version 




During the study period of 6 months, 438 confirmed 
dengue patients were admitted, amongst which 254 
were male (58%), and 184 were female (42%). The age 
of the children ranged from 04 months to 12 years, 
with a mean age of 8.03 years (SD + 3.13 years),  
 
Table 1: Demographic and Clinical Presentations 
Demographic and Clinical Presentations of Dengue 
Cases 
Gender Frequency (n=438) Percentage 
Male 254 58 
Female 184 42 
Age (mean 8.03 years SD + 3.13) 
Less than 1 year 15 3.4 
1-4 years 78 17.8 
5-8 years 114 26.1 
9-12 years 231 52.7 
 
In our study, out of 438 children, 254 (58%) were 
reported as uncomplicated dengue fever, 119 children 
(27%) developed dengue hemorrhagic fever and were 
managed accordingly. 65 children (15%) were into 
dengue shock syndrome and treated for this 
complication. 
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Table 2: Frequency of Dengue Fever and 
Complications 
Classification Frequency Percentage 




Dengue shock syndrome 65 15 
Total: 438 100 
In our study, the main findings were 
thrombocytopenia (80.1%) and leucopenia (65.1%). 
leucocyte count was normal in only 59 patients 
(13.68%). 351 (80.1%) patients had Thrombocytopenia 
(platelets less than 100,000). 30 (6.9%) patients had a 
platelet count of less than 50,000. Most of the patients 
were positive for NS1 (70.3%). IgM was positive in 
62.1% and IgG was positive in 14.8%. Enteric fever as a 
cop infection was seen in 30 patients, ALT was 
deranged in 42% of patients, and AST was elevated in 
27.85%. 
Table 3: Laboratory Findings. 









4.5 x 10³ 
(+ 2.5) 
1.1 x 10³ 18.6 x  10³ 
Hemoglobin 11.59 (+ 
2.32) 
4.9 mg/dl 16.9 
Platelets 82.6 x 10³ 
(+ 48.1) 











AST 262 (+ 
295) 
24 mg/dl 3598 
mg/dl 
 
COMPLETE BLOOD COUNT 











Platelet count <50,000 94 21.7 




NS1 Ag Positive 308 70.3 
Dengue IgM 272 62.1 
Dengue IgG 65 14.8 
Dengue IgM positive 
with NS1 negative 
97 22.1 
Thrombocytopenia, Leukopenia, HCT > 20% with 
Platelets <50,000, deranged LFTs, Hyponatremia, 
Hepato-spleenomegaly, and Gall bladder wall 
thickness on Ultrasonography were seen significantly 
associated with Progression of Disease and 
Development of Complications. 
 
Table 4: Significant Laboratory Parameters for Development of Complications 
SIGNIFICANT LABORATORY PARAMETERS FOR DEVELOPMENT OF COMPLICATIONS 








(Mean 4.5x10³  + 2.5 SD) 
<4,000 165 77 43 0.991 
4,000 – 10,000 83 37 20 
>10000 06 05 02 
Platelets  
(Mean  82.6  + 48.1 SD) 
>100,000 56 07 04 0.001 
50,000 – 100,000 95 102 48 
<50,000 03 10 17 
 HCT 
(33.84%  +  5.59 SD) 
>35 249 101 57 0.002 
<35 05 18 08 
 ALT 
(Mean  104  +  55 SD) 
<100 234 89 40 0.000 
100 - 1000 20 29 21 
>1000 00 01 04 
 AST 
(Mean  262  +  295 SD) 
<100 234 89 40 0.000 
100 - 1000 20 29 21 
>1000 00 01 04 
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Discussion 
 
Dengue infections are asymptomatic in 75% of infected 
humans. A spectrum of disease, from self-limiting 
dengue fever to haemorrhage and shock may be seen. 
A complex interaction of host and viral factors occur 
and determine whether the infection will be 
asymptomatic, typical, or severe.2 CBC parameters 
such as hemoglobin (Hb), hematocrit (Hct), WBC 
count, differential percentages of WBCs, and platelet 
count alter each day of fever in patients infected with 
dengue.10 Pancytopenia may develop after 3-4 days of 
illness.3 Early and accurate laboratory diagnosis of 
dengue virus infection is critical to effective patient 
management.5 
Amongst the age and sex ratio, the majority of the 
children are in the age group of 8-12 years, boys more 
commonly affected than girls with male to female ratio 
of 1.2:1. A similar age group with a mean age 
(standard deviation) of 6.9+3.3 years and a higher 
male to female ratio of 1.2:1 was found in a study by 
Potha pregada S et al.18 A study by Manoj Kumar et al. 
also shows a higher number of males affected with a 
male to female ratio of 1.54:1 among all seropositive 
cases.19 
The most significant laboratory abnormality seen in 
our study was thrombocytopenia. A study has shown 
thrombocytopenia in 59.8%.11 Another study has found 
thrombocytopenia in 67% of the cases.20 Significant 
derangements in platelets were found in yet another 
study.21 A study by Adel Hamed has documented 
thrombocytopenia in 74.45% of the patients.22 As 
platelet counts decrease the complication rate increase 
and duration of hospital stay increase with decreasing 
platelet count. Platelet count can therefore be used to 
predict the complication and duration of hospital stay 
and hence better use of resources.23  
In our study concomitant presence of leucopenia, 
raised haematocrit and low platelet count were 
commonly associated with dengue fever with warning 
signs. Leucopenia and differences in WBC count in 
dengue fever & dengue haemorrhagic fever have been 
found in a study by Juthatip Chaloemwong et al., 
demonstrating leucopenia (WBC count<5000 
cells/mm) in 70.9% of the patients during the acute 
febrile phase (day 2, 3) of illness with the average 
value in the acute febrile phase of 4.38 and 4.49 in 
those who progressed to dengue haemorrhagic fever. 
Other studies have documented leucopenia in 66% of 
patients22 and 26.5% of patients.11  
In our study liver enzymes were in the range of 10 – 
3500, with three children having a value of more than 
3000. ALT& AST levels were significantly increased 
among severe dengue cases compared to 
uncomplicated dengue fever cases. An elevation in 
AST (45.1%) and ALT (17.6%) were found in a study 
by Ferede et al. (11). Kularatam et al. has found that 
AST and ALT levels begin to rise in the early febrile 
phase with the median concentration of AST of 746 
u/L and ALT median concentration of 118 u/L.9  
In our study, hemoglobin levels varied between 4.9 
mg/dl and 16.9 mg/dl with a mean of 11.59 mg/dl (+ 
2.32), while hematocrit varied between 18.9% and 
52.7% with a mean of 33.84 (+5.59). Juthatip 
Chaloemwong et al. have demonstrated that there is 
significantly higher hematocrit and higher hemoglobin 
levels than the control group from day 3 to day 10 
with HB level of [14.3 gm/dl (13.98-14.55) vs 12.9 
gm/dl (12.59-13.38)] and hematocrit [43.3% (42.29-
43.89) vs 39.2% (38.42-40.67)] respectively.10 A study 
by Udya Ralapnawa et al. has shown Hb ranging from 
9 to 18 gm/dl during the fifth day of illness with an 
average value of 13.2 and 14.04 among DF and DHF 
patients respectively, while the mean packed cell 
volume (PCV) value for DF and DHF were 39.29 and 
47.49 respectively.24 Rise in Hct is more distinct, rapid, 
and significantly higher in DHF than in DF.9 In a study 
on various dengue syndromes a raised Hct was seen in 
13.2% of patients at the time of presentation.20 
Endothelial dysfunction leading to increased vascular 
permeability is a hallmark of severe dengue leading to 





Careful assessment and interpretation of 
hematological changes in pediatric dengue patients 
not only allow early diagnosis but also aid in adopting 
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